OTCBB:EHVVF
EHAVE, Inc. Stock News
$0.0010
+0 (+0%)
At Close: Jun 28, 2024
Ehave Hires Contract Research Organization To Conduct Ketamine Clinical Trial In Miami, Florida
08:30am, Tuesday, 12'th Oct 2021
Ehave one of the first companies to pioneer the collection of certain data points, as well as to seek to understand how ketamine can potentially resolve issues in the brain through a process called ne
Psychedelic Stock Review Initiates Coverage on Ehave Inc.
08:30am, Thursday, 30'th Sep 2021
MIAMI, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announc
Ehave Announces Inclusion in the 2021 Psychedelic Investor Guide
08:30am, Monday, 27'th Sep 2021
MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today that it
Ehave Appoints Board-Certified Gastroenterologist And Licensed Physician Dr. Rahul Dixit To Its Medical Advisory Board
08:30am, Tuesday, 21'st Sep 2021
MIAMI, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today Dr. Rahu
Ehave Announces Update On Ehave Medical App With The Launch Of Covid Vaccine Passport Going Live Shortly
09:49am, Tuesday, 07'th Sep 2021
Ehave's Covid Passport provides small businesses a tool to verify Covid-19 vaccination, and a suite of products to improve both the mental and overall health of individuals. Ehave's Covid Passport pro
Ehave Files 6-K Disclosing LOI Details For The Acquisition Of Moksha Digital Software
09:43am, Wednesday, 25'th Aug 2021
MIAMI, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announc
Ehave Accelerates Growth With LOI To Acquire India Based Moksha Digital, A Medical Imaging Software Provider
01:49pm, Tuesday, 24'th Aug 2021
MIAMI and BANGALORE, India, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventio
Ehave Files 6-K Disclosing Research Project Agreement
08:30am, Tuesday, 24'th Aug 2021
MIAMI, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announc
Ehave Releases Additional Information On Partnership With Cutting Edge Data Provider As It Expands Capabilities
08:30am, Tuesday, 13'th Jul 2021
Ehave to provide data integrity and patient privacy while allowing patients to share their medical data with medical providers and research organizations Ehave to provide data integrity and patient pr
Institutional Review Board (IRB) reviews proposed research protocols to protect human subjects involved in research. Institutional Review Board (IRB) reviews proposed research protocols to protect hum
Ehave, Inc. To Be One Of Four Main Sponsors At The Third Annual Psytech Summit on July 19th and 20th, 2021
08:30am, Friday, 02'nd Jul 2021
Sponsorship Opportunity for PsyTech Summit provides robust environment for awareness alongside some of the biggest names in the psychedelic industry Sponsorship Opportunity for PsyTech Summit provides
Health Wizz Co-Founder, Dr. Nitin Desai, To Assist And Advise Ehave On Mental Health Analytical Platforms
08:30am, Tuesday, 29'th Jun 2021
Ehave, Inc. ramps up to begin clinical trials by adding esteemed medical professional to its medical advisory board. Ehave, Inc. ramps up to begin clinical trials by adding esteemed medical profession
Dr. Jeffrey Kamlet Internationally Recognized Expert on Cardiac Safety in Ibogaine Treatment Joins Ehave as Chief Medical Officer
09:31am, Tuesday, 15'th Jun 2021
New Position Created to Deepen Clinical Expertise and Advance Pipeline Clinical Programs New Position Created to Deepen Clinical Expertise and Advance Pipeline Clinical Programs
Ehave KetaDASH Subsidiary Commences Data Collection for Potential Patients and Partnering Clinics
06:30am, Thursday, 20'th May 2021
Brings Ketamine treatments for anxiety, depression and PTSD to the home; Supports Ketamine clinics and mental health professionals. Brings Ketamine treatments for anxiety, depression and PTSD to the h
KetaDASH www.ketadash.com to be the first Intravenous (IV) based, home delivery platform for patients who have been prescribed Ketamine KetaDASH www.ketadash.com to be the first Intravenous (IV) based
